VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
HCSG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
HCSGHealthcare Services Group, Inc.
$24.28$1.7B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksHCSGFinancials

Healthcare Services Group, Inc. (HCSG) Income Statement

30Y historyFree accessUpdated daily

Revenue growth has decelerated to 3.3% in 2026Q3 from 8.5% a year prior, while gross margin has settled into a 15.9–16.8% band after the anomalous 20.5 swing between the 0.6% (2025Q2) and 20.8% (2025Q3) extremes.

Income StatementBalance SheetCash FlowRatios

HCSG Income Statement

Annual statement

HCSG Income Statement

Healthcare Services Group, Inc. (HCSG) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue1.88B1.84B1.72B1.67B1.69B1.64B1.76B1.84B2.01B1.87B1.56B1.44B1.29B1.15B1.08B889.07M773.96M692.7M602.72M577.72M511.63M466.29M442.57M379.72M328.5M284.19M254.67M232.4M204.9M181.4M162.5M
Revenue Growth %3.96%7.08%2.65%-1.11%2.94%-6.72%-4.37%-8.37%7.65%19.42%8.76%11.11%12.46%6.72%21.19%14.87%11.73%14.93%4.33%12.92%9.72%5.36%16.55%15.59%15.59%11.59%9.58%13.42%12.95%11.63%9.28%
Cost of Goods Sold1.57B1.6B1.49B1.46B1.5B1.41B1.49B1.61B1.77B1.61B1.34B1.24B1.16B995.1M930.81M766.96M665.15M597.72M521.27M493.36M438.62M406.11M388.72M334.61M289.86M252.03M226.9M203.6M172.3M152.3M137M
COGS % of Revenue-86.97%86.71%87.15%88.56%85.96%84.78%87.62%88.21%86.41%85.72%86.03%89.34%86.54%86.39%86.27%85.94%86.29%86.49%85.4%85.73%87.09%87.83%88.12%88.24%88.68%89.1%87.61%84.09%83.96%84.31%
Gross Profit307.15M239.41M228.09M214.75M193.31M230.57M267.99M227.9M236.84M253.62M223.17M200.74M137.89M154.79M146.62M122.11M108.81M94.98M81.45M84.36M73.01M60.18M53.85M45.11M38.64M32.16M27.77M28.8M32.6M29.1M25.5M
Gross Margin %16.34%13.03%13.29%12.85%11.44%14.04%15.22%12.38%11.79%13.59%14.28%13.97%10.66%13.46%13.61%13.73%14.06%13.71%13.51%14.6%14.27%12.91%12.17%11.88%11.76%11.32%10.9%12.39%15.91%16.04%15.69%
Gross Profit Growth %-4.96%6.21%11.09%-16.16%-13.96%17.59%-3.77%-6.62%13.64%11.17%45.58%-10.92%5.57%20.08%12.22%14.56%16.61%-3.45%15.54%21.33%11.75%19.38%16.74%20.15%15.81%-3.58%-11.66%12.03%14.12%6.25%
Operating Expenses193.66M190.87M174.82M160.09M149.52M166.43M267.99M150.02M136.6M126.73M105.42M111.69M107.81M92M79.28M65.31M57.31M50.27M39.52M40.28M37.2M32.58M31.52M29.04M25.15M21.87M19.62M20.9M19.5M19.8M15.2M
OpEx % of Revenue-10.39%10.19%9.58%8.85%10.14%15.22%8.15%6.8%6.79%6.75%7.77%8.34%8%7.36%7.35%7.4%7.26%6.56%6.97%7.27%6.99%7.12%7.65%7.66%7.7%7.7%8.99%9.52%10.92%9.35%
Selling, General & Admin193.66M190.87M174.82M160.09M149.52M166.43M141.58M150.02M136.6M126.73M105.42M111.69M107.81M92M79.28M65.31M57.31M50.27M39.52M40.28M37.2M32.58M31.52M29.04M25.15M21.87M19.62M18.8M17.4M17.7M13M
SG&A % of Revenue-10.39%10.19%9.58%8.85%10.14%8.04%8.15%6.8%6.79%6.75%7.77%8.34%8%7.36%7.35%7.4%7.26%6.56%6.97%7.27%6.99%7.12%7.65%7.66%7.7%7.7%8.09%8.49%9.76%8%
Research & Development0000000000000000000000000000000
R&D % of Revenue-------------------------------
Other Operating Expenses000000126.41M0000-62K0000000000000002.1M2.1M2.1M2.2M
Operating Income113.5M48.54M53.27M54.66M43.79M64.13M077.88M100.24M126.89M117.75M89.05M30.08M62.79M67.34M56.8M51.5M44.71M41.93M44.07M35.82M27.6M22.33M16.06M13.49M10.29M8.15M7.9M13.1M9.3M10.3M
Operating Margin %6.04%2.64%3.1%3.27%2.59%3.91%-4.23%4.99%6.8%7.54%6.2%2.33%5.46%6.25%6.39%6.65%6.45%6.96%7.63%7%5.92%5.04%4.23%4.11%3.62%3.2%3.4%6.39%5.13%6.34%
Operating Income Growth %--8.88%-2.54%24.82%-31.72%--100%-22.31%-21%7.76%32.23%196.05%-52.09%-6.77%18.56%10.3%15.18%6.64%-4.87%23.05%29.77%23.63%38.98%19.05%31.16%26.23%3.16%-39.69%40.86%-9.71%8.42%
EBITDA128.75M65.32M67.86M69M59.1M78.8M144.83M91.82M109.51M135.78M125.25M96.71M37.35M68.99M72.46M61.19M55.26M47.94M44.78M47.08M38.12M29.47M24.2M17.98M15.53M12.53M10.36M10M15.2M11.4M12.5M
EBITDA Margin %6.85%3.56%3.96%4.13%3.5%4.8%8.23%4.99%5.45%7.28%8.02%6.73%2.89%6%6.73%6.88%7.14%6.92%7.43%8.15%7.45%6.32%5.47%4.73%4.73%4.41%4.07%4.3%7.42%6.28%7.69%
EBITDA Growth %113.43%-3.74%-1.66%16.74%-24.99%-45.59%57.73%-16.15%-19.35%8.4%29.51%158.94%-45.86%-4.79%18.42%10.73%15.27%7.06%-4.88%23.48%29.35%21.79%34.6%15.79%23.92%20.94%3.6%-34.21%33.33%-8.8%3.31%
D&A (Non-Cash Add-back)15.25M16.78M14.59M14.34M15.32M14.67M14.27M13.94M9.27M8.89M7.5M7.66M7.27M6.2M5.12M4.39M3.76M3.23M2.85M3M2.31M1.87M1.87M1.91M2.03M2.24M2.21M2.1M2.1M2.1M2.2M
EBIT118.7M69.45M59.38M60.91M47.54M66.9M130.56M88.56M103M134.33M119.25M88.99M31.29M65.79M69.06M56.7M52.82M44.71M41.93M44.07M35.82M27.6M22.38M16.06M13.49M10.29M8.15M7.9M13.1M9.3M10.3M
Net Interest Income-739K-1.58M-6.44M-7.86M-2.99M-1.39M-1.37M-3.46M-3.09M-1.36M000000000000000000000
Interest Income0000000000000000000000000000000
Interest Expense739K1.58M6.44M7.86M2.99M1.39M1.37M3.46M3.09M1.36M000000000000000000000
Other Income/Expense14.33M19.33M-330K-1.6M764K1.38M129.19M7.22M2.07M6.08M2.63M712K1.63M3.7M1.2M1.01M2.62M4.62M1.35M4.02M4.91M3.2M1.33M1.45M771.47K1.25M988.9K800K1.3M1.4M1.2M
Pretax Income127.82M67.87M52.94M53.06M44.55M65.51M129.19M85.1M99.91M132.97M120.39M89.76M31.71M66.49M70.26M57.81M54.12M49.34M43.27M48.09M40.72M30.8M23.71M17.51M14.26M11.54M9.14M8.7M14.4M10.7M11.5M
Pretax Margin %6.8%3.69%3.09%3.17%2.64%3.99%7.34%4.62%4.97%7.13%7.7%6.25%2.45%5.78%6.52%6.5%6.99%7.12%7.18%8.33%7.96%6.61%5.36%4.61%4.34%4.06%3.59%3.74%7.03%5.9%7.08%
Income Tax22.95M8.81M13.47M14.67M10.31M16.97M30.5M20.52M16.39M44.74M42.99M31.74M9.86M19.36M26.05M19.66M19.68M18.99M16.66M18.52M15.27M11.7M9.01M6.66M5.63M4.5M3.55M3.2M5.5M4.8M4.6M
Effective Tax Rate %17.95%12.98%25.44%27.65%23.14%25.9%23.61%24.11%16.4%33.65%35.71%35.36%31.09%29.12%37.07%34%36.36%38.5%38.5%38.5%37.5%38%37.99%38%39.5%39.01%38.86%36.78%38.19%44.86%40%
Net Income104.88M59.06M39.47M38.39M34.24M48.54M98.68M64.58M83.52M88.23M77.4M58.02M21.85M47.13M44.21M38.16M34.44M30.34M26.61M29.58M25.45M19.1M14.7M10.86M8.63M7.04M5.59M5.5M8.9M5.9M6.9M
Net Margin %5.58%3.21%2.3%2.3%2.03%2.96%5.61%3.51%4.16%4.73%4.95%4.04%1.69%4.1%4.1%4.29%4.45%4.38%4.42%5.12%4.97%4.1%3.32%2.86%2.63%2.48%2.19%2.37%4.34%3.25%4.25%
Net Income Growth %163.94%49.63%2.83%12.1%-29.46%-50.81%52.8%-22.68%-5.33%13.99%33.39%165.56%-53.64%6.59%15.88%10.79%13.51%14.01%-10.02%16.21%33.28%29.91%35.35%25.83%22.68%25.91%1.6%-38.2%50.85%-14.49%76.92%
Net Income (Continuing)104.88M59.06M39.47M38.39M34.24M48.54M98.68M64.58M83.52M88.23M77.4M58.02M21.85M47.13M44.21M38.16M34.44M30.34M26.61M29.58M25.45M19.1M14.7M10.86M8.63M7.04M5.59M5.5M8.9M5.9M6.9M
Discontinued Operations0000000000000000000000000000000
Minority Interest0000000000000000000000000000000
EPS (Diluted)1.510.810.530.520.460.651.320.871.121.191.050.800.310.670.650.560.510.460.400.450.390.300.240.180.150.130.100.100.150.100.11
EPS Growth %181.13%52.83%1.92%13.04%-29.23%-50.76%51.72%-22.32%-5.88%13.33%31.25%158.06%-53.73%3.08%16.07%9.8%10.87%15%-11.11%15.38%30%25%33.33%20%15.38%30%3.31%-35.47%50%-9.09%74.05%
EPS (Basic)-0.820.540.520.460.651.320.871.131.201.060.810.310.680.650.570.520.470.410.470.410.320.250.190.150.130.100.100.160.100.11
Diluted Shares Outstanding69.38M73.03M73.99M74.34M74.35M74.96M74.78M74.59M74.61M74.35M73.47M72.51M71.34M70.05M68.48M67.58M67.01M66.43M66.04M65.77M64.72M63.72M62.23M60.03M59.18M55.65M55.47M56.82M58.51M58.95M61.81M
Basic Shares Outstanding68M72.38M73.75M74.29M74.34M74.82M74.7M74.36M74M73.36M72.75M71.83M70.62M69.21M67.51M66.64M65.92M65.38M64.7M63.43M61.76M60.57M59M57.54M57.02M55.65M55.47M55.69M57.03M57.44M61.81M
Dividend Payout Ratio----185.07%128.19%61.52%91.28%68.48%62.62%68.92%88.54%224.61%99.1%99.73%110.67%114.06%106.28%93.87%59.96%49.61%42.29%31.28%13.71%-------

Key Metrics

Growth RegimeDecelerating
ProfitabilityModerate
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

COGS volatility and regulatory labor mandate overhang

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Revenue Growth Decelerates Materially

HCSG's year-over-year revenue growth has slowed from 8.5% in 2025Q3 to 3.3% in 2026Q3, representing a clear deceleration trajectory. Management's raised guidance to $535M–$545M for full-year revenue suggests an acceleration is expected, but the sequential slowdown across recent quarters warrants scrutiny of underlying demand durability.

The deceleration pattern is pronounced: revenue growth peaked at 8.5% in 2025Q3, moderated to 6.6% in 2025Q4, then compressed further to 3.3–3.4% across the first three quarters of 2026. This trend is consistent with either census pressures at client SNF facilities or a maturing contract base where new facility wins are not keeping pace with organic pricing. The raised guidance, if achieved, would require a meaningful re-acceleration in the fourth quarter, which may suggest either conservative prior guidance or a favorable contract timing dynamic that could be non-recurring.

Gross Margin Volatility Defies Normalization

HCSG's gross margin swung from a catastrophic 0.6% in 2025Q2 to 20.8% in 2025Q3, then settled into a 15.9–16.8% range across the last four quarters, according to reported financial statements. This volatility suggests the structural cost base contains embedded risks—likely insurance or compensation adjustments—that materially distort period-to-period comparability.

The 2025Q2 collapse to $3.0M in gross profit on $458.5M of revenue was driven by an extraordinary COGS spike to $455.5M, far exceeding any prior or subsequent quarter. The immediate rebound to 20.8% in 2025Q3 suggests this was a one-time event—likely a workers' compensation or general liability adjustment as flagged in the company's accounting nuance disclosures—rather than an operational breakdown. However, the fact that margins have not returned to the pre-incident levels (13.4–14.8% in 2024) and instead stabilized higher at 15.9–16.8% suggests either a pricing reset or a shift in segment mix that may be structural. Relative to ABM's 11.7% gross margin, HCSG's recent 16.8% appears to reflect better cost pass-through, but the historical volatility makes this a less reliable signal.

2025Q2 COGS Spike Redefines Risk Profile

The 2025Q2 quarter—where COGS consumed 99.3% of revenue, producing a -$41.6M operating loss and -$32.4M net loss—represents the most consequential operational inflection in HCSG's recent history. The subsequent recovery in 2025Q3 suggests a non-recurring charge, but the episode reveals the thin margin structure offers limited absorption capacity for cost shocks.

The magnitude of the 2025Q2 anomaly is striking: COGS of $455.5M versus $390.5M in the immediately preceding quarter implies roughly $65M in excess costs that had no parallel in surrounding periods. While the data does not disclose the specific driver, the pattern is consistent with an insurance reserve adjustment or a one-time workers' compensation true-up, both of which are known volatility sources in HCSG's reporting history. The lasting impact appears to be twofold: management likely tightened expense controls and pricing discipline afterward, and the market may now apply a persistent risk discount to HCSG's earnings stream. With a 2.64% operating margin (as noted in company intelligence), there is structurally little buffer against recurrence of a similar event.

EPS Volatility Outpaces Revenue Stability

HCSG's quarterly EPS has ranged from -$0.44 (2025Q2) to $0.58 (2025Q3), a swing of $1.02 per quarter, while quarterly revenue varied only 12.5% across the same ten-quarter window. This disproportionate earnings volatility, compounded by SBC fluctuating between $2.1M and $3.7M, suggests reported EPS carries meaningful non-operational noise that complicates trend analysis.

The most recent EPS growth figure of -37.9% in 2026Q3 appears alarming in isolation, but this reflects a difficult comparison against the outsized $0.58 EPS printed in 2025Q3 rather than operational deterioration. Normalizing across the last four quarters (2025Q4–2026Q3), EPS averaged approximately $0.37, suggesting a more stable underlying earning power than headline volatility implies. Stock-based compensation has remained within a narrow $2.1–3.7M band and represents only 0.4–0.8% of revenue, so SBC is not a material EPS distortion relative to companies with heavier equity compensation programs. The net margin compression from 9.3% (2025Q3) to 5.2% (2026Q3) may reflect normalization from an exceptionally clean quarter rather than deterioration, but investors should verify whether the tax line or non-operating items are contributing.

Structural Risks Undermine Bull Case Durability

The case for sustained margin expansion at HCSG is undermined by three converging pressures: decelerating revenue growth at 3.3%, gross margins that have compressed 400bps from the 2025Q3 peak of 20.8% to 16.8%, and the unresolved federal nursing home staffing mandate that could structurally raise labor costs. The raised guidance may prove aggressive if these forces converge.

Revenue growth has halved in a year while gross margins, despite recent stabilization, remain well below the 20.8% level achieved just four quarters prior. The SG&A line also shows no clear efficiency gains—ranging from $42.0M to $52.6M over the last year with no discernible downward trend despite management's claims of disciplined cost control. A short-seller would argue that the current 16.8% gross margin may already reflect peak pricing power, and that the pending federal staffing mandate could simultaneously raise HCSG's own labor costs while compressing its clients' ability to pay. With an operating margin of just 6.7% in 2026Q3 and no visible leverage trajectory in SG&A as a percentage of revenue, even a modest wage inflation shock could push the company back toward breakeven earnings as seen in 2024Q2 and 2025Q2.

HCSG — Frequently Asked Questions

Quick answers to the most common questions about buying HCSG stock.

What was Healthcare Services Group, Inc.'s (HCSG) revenue in 2025?

For fiscal year 2025, Healthcare Services Group, Inc. (HCSG) reported total revenue of $1.84B. This represents a 1030.6% increase compared to $162.5M in 1996.

Is Healthcare Services Group, Inc. (HCSG) profitable?

Healthcare Services Group, Inc. (HCSG) is profitable, generating $59.1M in net income for the fiscal year ending 2025 with a net profit margin of 3.2%.

What is Healthcare Services Group, Inc.'s operating profit margin?

Healthcare Services Group, Inc. (HCSG) reported an operating income of $48.5M, resulting in an operating profit margin of 2.6%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Healthcare Services Group, Inc.'s gross profit and gross margin?

Healthcare Services Group, Inc. (HCSG) generated $239.4M in gross profit for the year, representing a gross profit margin of 13.0%. This demonstrates the company's core pricing power and production efficiency.